HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Raf-1 expression may influence progression to androgen insensitive prostate cancer.

AbstractBACKGROUND:
Recent evidence has implicated the MAP kinase pathway with the development of androgen insensitive prostate cancer (AIPC). We have previously reported gene amplification of critical members of this pathway with the development of androgen insensitive disease.
METHODS:
Protein expression of Raf-1 was analyzed using immunohistochemistry (IHC) in a database of 65 paired tumor specimens obtained before and after the development of AIPC and correlated with other members of the pathway.
RESULTS:
Patients whose Raf-1 expression rose with development of AIPC had a significantly shorter median time to biochemical relapse compared to those whose expression fell or remained unchanged (1.16 vs. 2.62 years, P = 0.0005). In AIPC tumors, expression of Raf-1 correlated significantly with expression of HER2 and with expression of c-fos.
CONCLUSIONS:
We conclude that the HER2/Raf-1/AP-1 axis may promote the development of AIPC, leading to early relapse. Members of the pathway may act as novel therapeutic targets for patients.
AuthorsR Mukherjee, J M S Bartlett, N S Krishna, M A Underwood, J Edwards
JournalThe Prostate (Prostate) Vol. 64 Issue 1 Pg. 101-7 (Jun 15 2005) ISSN: 0270-4137 [Print] United States
PMID15666389 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgens
  • Proto-Oncogene Proteins c-raf
Topics
  • Androgens (metabolism)
  • Disease Progression
  • Humans
  • Immunohistochemistry
  • MAP Kinase Signaling System (physiology)
  • Male
  • Prostatic Neoplasms (metabolism, pathology)
  • Proto-Oncogene Proteins c-raf (metabolism)
  • Recurrence
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: